Presenting IgnitePLASMA research at the French liver congress
99th Scientific Meeting of the French Association for the Study of the Liver (AFEF)
24/10/2026
The congress brought together clinicians, researchers and industry representatives working on liver diseases, with particular attention to the links between basic research and clinical practice. Marion’s poster was displayed electronically, and she discussed the work with attendees and exchanged ideas with other participants.
🔗 AFEF 2026 congress
Acknowledgement:
The project IgnitePLASMA is funded by the European Union (Call: HORIZON-EIC-2023-PATHFINDER OPEN-01; grant number: 101129853). UK participants in Horizon Europe Project ‘A minimally Invasive surgical platform aGainst paNcreatIc and biliary Tract cancErs using cold atmospheric PLASMA’ are supported by UKRI grant numbers 10106237 to Synnous Limited.
Disclaimer:
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.
Strasbourg, 7-9 October 2026
Marion Janona (NABI UMR 8175 / U1334) presented a poster titled “Innocuity and selectivity of cold atmospheric plasma in digestive cancers” at the AFEF congress.
The research work extends to address mainly three cancer types: cholangiocarcinoma (bile duct cancer), hepatocellular carcinoma (liver cancer) and pancreatic ductal adenocarcinoma (pancreatic cancer). Innocuity concerns whether a treatment spares healthy cells, and selectivity whether it acts on cancer cells. Both matter for IgnitePLASMA, which is developing a minimally invasive surgical platform using cold atmospheric pressure plasma (CAPP) against pancreatic and biliary tract cancers.
Read the post on LinkedIn
The congress brought together clinicians, researchers and industry representatives working on liver diseases, with particular attention to the links between basic research and clinical practice. Marion’s poster was displayed electronically, and she discussed the work with attendees and exchanged ideas with other participants.
🔗 AFEF 2026 congress
Acknowledgement:
The project IgnitePLASMA is funded by the European Union (Call: HORIZON-EIC-2023-PATHFINDER OPEN-01; grant number: 101129853). UK participants in Horizon Europe Project ‘A minimally Invasive surgical platform aGainst paNcreatIc and biliary Tract cancErs using cold atmospheric PLASMA’ are supported by UKRI grant numbers 10106237 to Synnous Limited.
Disclaimer:
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.
